Skip to main content
. 2020 Mar 11;18(1):1660. doi: 10.18549/PharmPract.2020.1.1660

Table 4. Counselling information about product.

 Counselling regarding product Yes No Percentage
A product was suggested 94 6 94.0%
A description of the product was provided 87 7 92.6%
The mode of action was explained 52 42 55.3%
Treatment expectations were provided 50 44 53.2%
Duration of use was discussed 41 53 43.6%
Dosage was suggested 62 32 66.0%
Side effects (or lack) of were explained 16 78 17.0%